Sandu Pharmaceuticals Ltd — Updates, 30-05-2025: Company Update

Sandu Pharmaceuticals has announced a board meeting on 28 May 2025 to approve the financial results for the quarter and half-year. The consolidated total income from operations declined to Rs 1413.85 lakhs in the latest quarter from Rs 1839.74 lakhs in the previous quarter, with a net profit after tax of Rs 32.64 lakhs. For the full year, total income stood at Rs 6735.99 lakhs with a net profit after tax of Rs 155.17 lakhs, reflecting marginal growth over the previous year. Earnings per share for the year were Rs 1.60. The company continues operations steadily, with comprehensive income showing a positive trend.